Accel Therapies Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Accel Therapies's estimated annual revenue is currently $32.1M per year.(i)
  • Accel Therapies's estimated revenue per employee is $270,000

Employee Data

  • Accel Therapies has 119 Employees.(i)
  • Accel Therapies grew their employee count by 10% last year.

Accel Therapies's People

NameTitleEmail/Phone
1
Director OperationsReveal Email/Phone
2
Regional Clinical DirectorReveal Email/Phone
3
Associate Clinical DirectorReveal Email/Phone
4
Case ManagerReveal Email/Phone
5
Clinical Supervisor (BCBA)Reveal Email/Phone
6
Senior Program SupervisorReveal Email/Phone
7
Behavioral Health TechnicianReveal Email/Phone
8
Behavioral Health TechnicianReveal Email/Phone
9
Clinical SupervisorReveal Email/Phone
10
Behavioral Health TechnicianReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.3M156-3%N/AN/A
#2
$148.5M440N/AN/AN/A
#3
$124.2M36846%N/AN/A
#4
$545.1M144217%N/AN/A
#5
$29.2M1086%N/AN/A
#6
$12.9M53N/AN/AN/A
#7
$1125.1M29146%$20.4MN/A
#8
$15.3M6315%N/AN/A
#9
$8.9M415%N/AN/A
#10
$4.3M23-15%N/AN/A
Add Company

What Is Accel Therapies?

Through evidence-based methods and a results-driven philosophy, our professionals and staff help children and their families enjoy meaningful, tangible progress as they achieve their developmental goals. We specialize in Applied Behavior Analysis (ABA) and other therapies. What sets us apart is our focus on an individual connection with our clients and our commitment to life-changing outcomes for families. We are passionate about what we do and continuously searching for dedicated professionals and staff who share our mission, vision, and values to join our team.

keywords:N/A

N/A

Total Funding

119

Number of Employees

$32.1M

Revenue (est)

10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$27M1194%N/A
#2
$30.1M12079%N/A
#3
$25.3M125-5%$11.8M
#4
$25.6M125-6%$14.5M
#5
$33M1308%N/A